We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.04B
Cap. Flow %
8.47%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,117
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOLD
2976
Gold.com Inc
GOLD
$1.24B
-117,616
Closed -$2.73M
AMRN
2977
Amarin Corp
AMRN
$297M
-4,942
Closed -$433K
AMSF icon
2978
AMERISAFE
AMSF
$525M
-16,150
Closed -$964K
AOSL icon
2979
Alpha and Omega Semiconductor
AOSL
$1.05B
-18,552
Closed -$564K
AOUT icon
2980
American Outdoor Brands
AOUT
$161M
-44,234
Closed -$1.55M
APA icon
2981
APA Corp
APA
$14.4B
-64,229
Closed -$1.39M
APD icon
2982
Air Products & Chemicals
APD
$68.6B
-7,761
Closed -$2.23M
API
2983
Agora
API
$396M
-299,880
Closed -$12.6M
APLS
2984
DELISTED
Apellis Pharmaceuticals
APLS
-10,375
Closed -$656K
APO icon
2985
Apollo Global Management
APO
$80.8B
-59,506
Closed -$3.7M
APPF icon
2986
AppFolio
APPF
$7.16B
-18,041
Closed -$2.55M
ARDX icon
2987
Ardelyx
ARDX
$997M
-3,348,363
Closed -$25.4M
AREC icon
2988
American Resources Corp
AREC
$306M
-205,278
Closed -$523K
ARQT icon
2989
Arcutis Biotherapeutics
ARQT
$3.33B
-15,138
Closed -$413K
ARVN icon
2990
Arvinas
ARVN
$587M
-511,147
Closed -$39.4M
ARWR icon
2991
Arrowhead Research
ARWR
$12.7B
-250,380
Closed -$20.7M
ARW icon
2992
Arrow Electronics
ARW
$10.5B
-10,442
Closed -$1.19M
ASAN icon
2993
Asana
ASAN
$2.14B
-27,179
Closed -$1.69M
ASC icon
2994
Ardmore Shipping
ASC
$661M
-61,274
Closed -$258K
ATEC icon
2995
Alphatec Holdings
ATEC
$1.47B
-178,204
Closed -$2.73M
ATEX icon
2996
Anterix
ATEX
$1.84B
-7,250
Closed -$435K
AUTL
2997
Autolus Therapeutics
AUTL
$604M
-297,749
Closed -$1.98M
AVY icon
2998
Avery Dennison
AVY
$13.6B
-40,799
Closed -$8.58M
AXTA icon
2999
Axalta
AXTA
$7.97B
-41,464
Closed -$1.26M
BA icon
3000
CALL
Boeing
BA
$185B
-3,800
Closed -$911K

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.04B of net new capital in Q3 2021, opening 1,117 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,117 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.